SCHEMBL597719

SCHEMBL597719

CCCc1ccc(C(C)C)cc1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.50
LPL P06858 1/20 0.46
LIPG Q9Y5X9 1/20 0.46
ACACB O00763 2/20 0.45
UCHL3 P15374 2/20 0.44
CA2 P00918 1/20 0.43
ALDH1A1 P00352 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KMT2A Q03164 1/20 0.41
ACACA Q13085 1/20 0.41
PYCR1 P32322 1/20 0.41
FKBP1A P62942 1/20 0.41
MGLL Q99685 1/20 0.41
PLK1 P53350 1/20 0.41
SIGMAR1 Q99720 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5275137 0.93 ACACB (0.49) IDO1LPLLIPGACACBUCHL3
SCHEMBL27708207 0.89 RAB9A (0.51) ALDH1A1L3MBTL1KMT2ASIGMAR1
SCHEMBL426393 0.88 IDO1 (0.41) IDO1LPLLIPGACACBUCHL3
SCHEMBL7194014 0.88 RAB9A (0.47) IDO1ACACBUCHL3ALDH1A1L3MBTL1
SCHEMBL6551663 0.88 ACACB (0.42) IDO1LPLLIPGACACBUCHL3
SCHEMBL6142519 0.88 ACACB (0.49) IDO1LPLLIPGACACBUCHL3
SCHEMBL10729588 0.87 IDO1 (0.56) IDO1ALDH1A1L3MBTL1KMT2APYCR1
SCHEMBL8090819 0.86 UCHL3 (0.56) IDO1UCHL3CA2ALDH1A1PLK1
SCHEMBL9621041 0.85 LPL (0.46) LPLLIPGACACBCA2ALDH1A1
Isopropylbenzene SCHEMBL10951391 0.84 SIGMAR1 (0.49) ALDH1A1L3MBTL1KMT2ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320436-A1 CONSUMER PRODUCTS CONTAINING MALODOR COUNTERACTING COMPOUNDS PROCTER & GAMBLE (US) 2025-10-16 US disclosed
EP-3257510-B1 LACTATE DEHYDROGENASE INHIBITOR AND ANTIEPILEPTIC DRUG CONTAINING SAME NAT UNIV CORPORATION OKAYAMA UNIV (JP) 2021-10-20 EP disclosed
CN-110423185-A Method for selectively oxidizing cumene compound UNIV ZHEJIANG TECHNOLOGY 2019-11-08 CN disclosed
CN-103947031-B Organic electrolyte and organic electrolyte secondary battery 吉坤日矿日石能源株式会社 2017-07-11 CN disclosed
CN-104025364-B Organic bath and organic bath accumulator 吉坤日矿日石能源株式会社 2017-03-08 CN disclosed
US-9562113-B2 Labeled alginate conjugates for molecular imaging applications BELLEROPHON BCM LLC (US) 2017-02-07 US disclosed
CN-104025364-A Organic electrolyte, and organic electrolyte storage battery JX NIPPON OIL & ENERGY CORP 2014-09-03 CN disclosed
CN-104011928-A Organic electrolyte, and organic electrolyte storage battery JX NIPPON OIL & ENERGY CORP 2014-08-27 CN disclosed
CN-103947031-A Organic electrolyte and organic electrolyte secondary battery JX NIPPON OIL & ENERGY CORP 2014-07-23 CN disclosed
US-20120202766-A1 N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS PHARMASSET, INC. (US) 2012-08-09 US disclosed
US-5292719-A Perfumes, colognes, soaps and cosmetics; musk aroma UNION CAMP CORPORATION (US) 1994-03-08 US disclosed
EP-0390308-A1 Process for preparing polyalkyl tetrahydronaphthalenes Union Camp Corporation (US) 1990-10-03 EP disclosed
EP-0381353-A1 Process for preparing polyalkyl tetrahydronaphthalenes Union Camp Corporation (US) 1990-08-08 EP disclosed
US-4877913-A Process for preparing polyalkyl tetrahydronaphthalenes UNION CAMP CORPORATION (US) 1989-10-31 US disclosed
US-4877915-A Process for preparing polyalkyl tetrahydronaphthalenes UNION CAMP CORPORATION (US) 1989-10-31 US disclosed
US-4877911-A Process for preparing polyalkyl tetrahydronaphthalenes UNION CAMP CORPORATION (US) 1989-10-31 US disclosed
US-4877916-A Process for preparing polyalkyl tetrahydronaphthalenes UNION CAMP CORPORATION (US) 1989-10-31 US disclosed
US-4877914-A CATALYTIC CYCLIZATION, ALKYLATION UNION CAMP CORPORATION (US) 1989-10-31 US disclosed
US-4877910-A Process for preparing polyalkyl tetrahydronaphthalenes UNION CAMP CORPORATION (US) 1989-10-31 US disclosed
US-3941786-A Process for the production of 4-hydroxy-6-hydroxymethylpyrimidine LONZA LTD. (CH) 1976-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202766-A1 N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS ENTPD5, DUT, NT5C3B IDO1 1016/4885LPL 2738/4885LIPG 2687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.